Product Information
CLINDAMYCIN PH 1% GEL is a generic product labeled by NorthStar Rx LLC, priced at $0.1424 per GM under NDC 16714016101. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Feb 10, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
NorthStar Rx LLCNDC
16714016101
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA214251FDA Approved
2/10/2021
TE Code
AB1
On Market Since
3/10/2021
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PH 1% GEL has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 78.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1424 per GM |
|---|---|
| All-time high | $0.6761 (Apr 13, 2022) |
| All-time low | $0.1372 (Jul 22, 2026) |
| 52-week high | $0.1599 |
| 52-week low | $0.1372 |
| Median price | $0.2656 |
| Average price | $0.3052 |
| Largest weekly change | -40.7% (Oct 23, 2024) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PH 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PH 1% GEL, manufactured by NorthStar Rx LLC, is $0.1424 per GM (NDC 16714016101), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PH 1% GEL changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PH 1% GEL has declined 78.9%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PH 1% GEL?
Since Mar 23, 2022, the NADAC for CLINDAMYCIN PH 1% GEL has ranged from a low of $0.1372 (Jul 22, 2026) to a high of $0.6761 (Apr 13, 2022), with a median of $0.2656 per GM.
Are there cheaper alternatives to CLINDAMYCIN PH 1% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PH 1% GEL, is $0.1307 per GM — about 8% below CLINDAMYCIN PH 1% GEL.
Who manufactures CLINDAMYCIN PH 1% GEL?
CLINDAMYCIN PH 1% GEL (NDC 16714016101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.